myTomorrows

myTomorrows provides physicians and patients that are excluded from clinical trials access to innovative drugs in development. The Company focuses on disease areas with high unmet needs; oncology, neurology, psychiatry and rare diseases. myTomorrows identifies innovative drugs, informs physicians and patients and facilitates requests for access to these drugs in development.
Company Growth (employees)
Type
Private
HQ
Amsterdam, NL
Founded
2013
Size (employees)
64 (est)
myTomorrows was founded in 2013 and is headquartered in Amsterdam, NL

myTomorrows Office Locations

myTomorrows has an office in Amsterdam
Amsterdam, NL (HQ)
45 Pilotenstraat

myTomorrows Data and Metrics

Summary Metrics

Founding Date

2013

Total Funding

$22.1 m

Latest funding size

$10.5 m

Time since last funding

7 months

Investors

myTomorrows's latest funding round in January 2017 was reported to be $10.5 m. In total, myTomorrows has raised $22.1 m

Traffic Overview of myTomorrows

myTomorrows Online and Social Media Presence

myTomorrows News and Updates

Amsterdam-based myTomorrows raises €10 million to improve access to drugs in development

Amsterdam-based myTomorrows, a platform to help patients and doctors access drugs in development, has closed a €10 million growth funding round. The round was led by EQT Ventures and Octopus Ventures, with participation from existing investors Balderton Capital and Sofinnova Partners. The post Amste…

MyTomorrows raises $10.5 million to connect doctors and patients with early-stage drug programs

MyTomorrows, an online platform that connects physicians and patents to early-stage drug research and development programs, has raised €10 million ($10.5 million) in a funding round co-led by Octopus Ventures and EQT Ventures, with participation from existing investors Balderton Capital and Sofinnov…

MyTomorrows raises further €10M to help access drugs in development

 MyTomorrows, the Netherlands-headquartered startup that has built a platform to help physicians and patients access drugs that are still in development, has raised €10 million in further funding. Leading the round is EQT Ventures, and Octopus Ventures, with participation from existing backers Balde…

myTomorrows Company Life and Culture

You may also be interested in